Groundbreaking Results in Adolescents Spark Hope for Expanded PKU Treatment
A breakthrough in PKU treatment emerges with promising Phase 3 PEGASUS trial results. Palynziq, an enzyme therapy, significantly reduced blood phenylalanine levels in adolescents aged 12 to 17. The trial…